Evolus, Inc. (EOLS) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Evolus, Inc. Common Stock.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.196 Good afternoon, everyone, and thank you for standing by. 00:00:03.196 -- 00:00:08.143 Welcome to Evalyst's third quarter earnings conference call. 00:00:08.143 -- 00:00:12.889 If you require operator assistance during the conference, please press star zero. 00:00:12.889 -- 00:00:17.296 As a reminder, today's conference is being recorded and webcast live. 00:00:17.296 -- 00:00:20.440 All participants are in a listen-only mode. 00:00:20.440 -- 00:00:24.550 After the speaker's remarks, there will be a question and answer session. 00:00:24.550 -- 00:00:29.259 I would now like to turn the conference over to Narek Segarian, Vice President and Head 00:00:29.259 -- 00:00:32.807 of Global Investor Relations and Corporate Communications. 00:00:32.807 -- 00:00:35.288 Please go ahead. 00:00:35.512 -- 00:00:40.061 Thank you, Operator, and welcome to everyone joining us on today's call to review Evelis' 00:00:40.061 -- 00:00:45.392 third quarter financial results. Our third quarter press release is now on our website 00:00:45.392 -- 00:00:47.197 at evelis.com. 00:00:47.197 -- 00:00:52.623 With me today are David Morosetti, President and Chief Executive Officer, Tatiana Mitchell, 00:00:52.623 -- 00:00:58.650 Chief Financial Officer, and Rui Avalar, Chief Medical Officer and Head of R&D. 00:00:58.650 -- 00:01:01.814 Today's call will include forward-looking statements. 00:01:01.814 -- 00:01:06.479 Actual results may differ materially due to risks and uncertainties outlined in our earnings 00:01:06.479 -- 00:01:11.464 press release and the SEC filings. These forward-looking statements are based on current 00:01:11.464 -- 00:01:15.445 assumptions, and we undertake no obligation to update them. 00:01:15.445 -- 00:01:19.411 Additionally, we will discu...